Burlingame, CA, United States of America

Aaron Sato

USPTO Granted Patents = 77 (Patent Applications = 53)

CIPO Patents = 7 (Patent Applications = 17)

EPO Patents = 5 (Patent Applications = 36)

Average Co-Inventor Count = 3.9

ph-index = 16

Forward Citations = 625(Granted Patents)

Forward Citations (Not Self Cited) = 485(Dec 10, 2025)

Location History:

Somerville, MA (US) (2006 - 2009)
Richmond, CA (US) (2010 - 2017)
Burlingame, CA (US) (2011 - 2024)

Company Filing History:

29 out of 94

Oncomed Pharmaceuticals, Inc.

Twist Bioscience Corporation

Surrozen Operating, Inc.

patents

6. 5 out of 52

Sutro Biopharma, Inc.

patents

7. 2 out of 108

Bracco International Bv

patents

8. 2 out of 14

Syntonix Pharmaceuticals, Inc.

patents

9. 2 out of 3

Collagen Medical, LLC

Biogen Hemophilia Inc.

patents

12. 1 out of 4

Mereo Biopharma 5, Inc.

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

GLP1R Variants

Bispecific Antibodies

SARS-CoV-2 Antibodies

Nucleic Acid Libraries

Wnt Surrogate Molecules

Anti-CD3 Epsilon Antibodies

Adenosine Receptors

Anti-CD47 Antibodies

VEGF Binding Agents

Cancer Treatment Compositions

HGF Receptor Binding Peptides

Multivalent Constructs

77 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391762 - Methods and compositions relating to GLP1R variants (2025-08-19),

2. 12331427 - Antibodies that bind GLP1R (2025-06-17),

3. 12325739 - Bispecific SARS-CoV-2 antibodies and methods of use (2025-06-10),

4. 12304965 - Variant nucleic acid libraries for coronavirus (2025-05-20),

5. 12297278 - Wnt surrogate molecules and uses thereof (2025-05-13),

6. 12258406 - Antibodies that bind CD3 Epsilon (2025-03-25),

7. 12202905 - Methods and compositions relating to adenosine receptors (2025-01-21),

8. 12201857 - Methods and compositions relating to covid antibody epitopes (2025-01-21),

9. 12173282 - Antibodies that bind CD3 epsilon (2024-12-24),

10. 12134656 - Dickkopf-1 variant antibodies and methods of use (2024-11-05),

11. 12091777 - Variant nucleic acid libraries for CRTH2 (2024-09-17),

12. 12018065 - Variant nucleic acid libraries for coronavirus (2024-06-25),

13. 12006368 - Anti-frizzled antibodies and methods of use (2024-06-11),

14. 11958891 - Tissue-specific Wnt signal enhancing molecules and uses thereof (2024-04-16),

15. 11787860 - Anti-CD47 antibodies and uses thereof (2023-10-17),

Title: The Innovative Journey of Aaron Sato

Introduction: Aaron Sato, a visionary inventor based in Burlingame, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Aaron Sato's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles, a revolutionary medical device for non-invasive surgery, and a sustainable energy solution for urban environments.

Career Highlights: With over 20 years of experience in the tech industry, Aaron Sato has a proven track record of turning innovative ideas into reality. He has worked for leading tech companies, spearheading research and development projects that have pushed the boundaries of what is possible.

Collaborations: Throughout his career, Aaron Sato has collaborated with top engineers, scientists, and designers from around the world. His ability to work effectively in multidisciplinary teams has led to the successful development of groundbreaking technologies that have had a lasting impact on society.

Conclusion: Aaron Sato's passion for innovation and his relentless pursuit of excellence have established him as a trailblazer in the world of technology. His inventions continue to shape the future and inspire the next generation of inventors.

This text is generated by artificial intelligence and may not be accurate.